Nasdaq Buoyed by Biotech

The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector. Celgene Corporation of Summit, NJ, was upgraded from “Neutral” to “Outperform” by Robert W. Baird & Co. An upgrade is seen as a sign that analysts have confidence in the...

Potential Breakthrough in Search for AIDS Vaccine

Scientists at the Scripps Research Institute have isolated two antibodies that can prevent patients with HIV from developing severe AIDS. The discovery is a potential breakthrough in the 20-year search for an AIDS vaccine. According to a report in the journal Science, the antibodies have two major...

Heart Failure Society of America Holds Annual Meeting

A roundup of corporate news from the Heart Failure Society of America‘s annual meeting, which took place from Sept. 13-16 in Boston: Corventis, a developer of wireless cardiovascular solutions, has completed enrollment  in the company’s MUSIC (Multi-Sensor Monitoring in Congestive Heart Failure)...

Seaside Therapeutics Secures $30M to Fight Autism

Seaside Therapeutics has received $30 million in funding from a private, unnamed family investment firm committed to finding treatments for autism and Fragile X Syndrome.  The money will be used to fund the development drug candidates for these disorders. With the new financing, Seaside has raised $66...

Xenoport Reports Positive Data for Chronic Pain Drug

Most people wouldn’t think that a case of chicken pox could cause chronic pain, but many people across the U.S. feel the effects of this common childhood disease years after the red spots have disappeared. When the initial infection heals, some of the virus remains dormant in the body. Years later, it...

First Swine Flu Vaccines Approved

The U.S. government has approved swine flu vaccines from four pharmaceutical companies, Reuters reports. CSL, Medimmune, Novartis, and Sanofi-Aventis received approval from the U.S. Food and Drug Administration for their H1N1 vaccines. The new vaccines will be available within four weeks. There has been some...

[Company Profile] Urovalve

Chronic urinary retention, or the inability to empty the bladder at will, may seem like a mere inconvenience compared to other men’s health issues such as prostate cancer or heart disease. However, men with acute or chronic urinary retention find that the condition limits their normal activities,...

OneMedPlace Interviews Richard T. Schumacher, CEO of Pressure Biosciences

We recently reported on Pressure BioSciences (PBIO), a life-sciences tools company that has developed a unique method for extracting DNA, RNA, and proteins from cell and tissue samples. Whereas currently available techniques may alter or destroy the biomolecules,  Pressure Biosciences’ ...